Human antibodies from Dengue patients effectively treat Zika infection in mice

The team, led by researchers at Imperial College London and Washington University in St Louis, found that giving Zika-infected mice the antibodies was enough to treat the early stages of infection, and even protected unborn pups in pregnant animals.

According to the researchers, if the findings can be replicated in humans, the discovery could potentially lead to a single therapy to protect against both viral threats.